Revenue ₹278 Cr (+14% YoY)
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Concord Biotech LimitedConcord Biotech reported Q3 FY26 revenue of ₹278 crore, up 14% YoY, driven by API growth of 24% to ₹219 crore.
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.